[{"Assets_0_Q3_USD":9211500000.0,"CommonStockSharesConverted_0_Q3_shares":365625000.0,"CommonStockSharesOutstanding_0_Q3_shares":365625000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":347800000.0,"NetIncomeLossConverted_1_Q3_USD":60200000.0,"NetIncomeLossConverted_3_Q3_USD":70100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":365625000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":365265000.0,"StockholdersEquity_0_Q3_USD":5137100000.0,"EarningsPerShareBasic_1_Q3_USD":0.16,"EarningsPerShareBasic_3_Q3_USD":0.19,"RevenuesConverted_1_Q3_USD":761100000.0,"RevenuesConverted_3_Q3_USD":2267500000.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20181108"}]